Effects of nicergoline on the retinal and cortical electrophysiological responses in glaucoma patients: A preliminary open study

Pharmacological Research

Volumn 40, Issue 3, 1999, Pages 249-255

  Parisi, Vincenzo ^a,b,c   Colacino, Gaspare ^a,b   Milazzo, Giovanni ^d   Scuderi, Anna Claudia ^d   Manni, Gianluca ^a,b  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b Fondazione l'Oftalmol GB Bietti   (Italy)

^c IRCCS ISTITUTO CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI   (Italy)

^d SIFI SpA   (Italy)

Author keywords

Glaucoma; Innermost retinal layer; Nicergoline; Pattern electroretinogram; Visual evoked potentials; Visual function; Visual pathways

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CEBRAN; NICERGOLINE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL TRIAL; ELECTROPHYSIOLOGY; ELECTRORETINOGRAM; EVOKED VISUAL RESPONSE; HUMAN; MAJOR CLINICAL STUDY; OPEN ANGLE GLAUCOMA; PRIORITY JOURNAL; RETINA; TOPICAL DRUG ADMINISTRATION; VISUAL CORTEX;

EID: 0032878707     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1006/phrs.1999.0507     Document Type: Article

References (40)

1. Werner EB, Piltz-Seymour J. What constitutes a glaucomatous visual field defects. Sem Ophthalmol 1992; 7: 110-19.
2. Gunduz K, Arden GB, Perry S, Weinstein GW, Hitchings RA. Colour vision defects in ocular hypertension and glaucoma. Quantification with a computer driven colour television system. Arch Ophthal 1988; 106: 929-35.
3. Pomerance GN, Evans DW. Test-retest reliability of the CVS1000 contrast test and its relationship to glaucoma therapy. Invest Ophtahlmol Vis Sci 1994; 35: 3357-61.
4. Celesia GG, Kaufman D, Cone SB. Simultaneous recording of pattern electroretinography and visual evoked potentials in multiple sclerosis. A method to separate demyelination from axonal damage to the optic nerve. Arch Neurol 1986; 43: 1247-52.
5. Siliprandi R, Bucci MG, Canella R, Carmignoto G. Flash and pattern electroretinograms during and after acute intraocular pressure elevation in cat. Invest Ophthalmol Vis Sci 1988; 29: 558-65.
6. Marx MS, Podos SM, Bodis-Wollner I, Howard-Williams JR, Siegel MJ Teitelbaun CS, Maclin EL, Severin C. Flash and pattern electroretinograms in normal and laser-induced glaucomatous eyes. Invest Ophthalmol Vis Sci 1986; 27: 378-86.
7. Graham SL, Wong VAT, Drance SM, Mikelberg FS. Pattern electroretinograms from hemifields in normal subjects and patients with glaucoma. Invest Ophthalmol Vis Sci 1994; 35: 3347-56.
8. Marx MS, Bodis-Wollner I, Lustgarten JS, Podos SM. Electrophysiological evidence that early glaucoma affects foveal vision. Doc Ophthalmol 1988; 67: 281-301.
9. Marx MS, Bodis-Wollner I, Podos SM, Teitelbaun CS. The pattern ERG and VEP in glaucomatous optic nerve disease in the monkey and human. In: Evoked potentials. Cracco RQ, Bodis-Wollner I, eds. New York: Alan R Liss Inc, 1986: 117-26.
10. O'Donaghue E, Arden GB, O'Sullivan F, Falcao-Reis F, Mariarty B, Hitchings RA, Spileers W, Hoggs C, Weinstein G. The pattern electroretinogram in glaucoma and ocular hypertension. Br J Ophthalmol 1992; 76: 387-94.
11. Parisi V, Pernini C, Guinetti C, Neuschuler R, Bucci MG. Electrophysiological assessment of visual pathways in glaucoma. Eur J Ophthalmol 1997; 7: 229-35.
12. Pfeiffer N, Tillmon B, Bach M. Predictive value of the pattern electroretinogram in highrisk ocular hypertension. Invest Ophthalmol Vis Sci 1993; 34: 1710-15.
13. Porciatti V, Falsini B, Brunori S, Colotto A, Moretti G. Pattern electroretinogram as a function of spatial frequency in ocular hypertension and early glaucoma. Doc Ophthalmol 1987; 65: 349-55.
14. Wanger P, Persson HE. Pattern reversal electroretinograms in unilateral glaucoma. Invest Ophthalmol Vis Sci 1983; 24: 749-53.
15. Watanabe I, Iijinn H, Tsukahara S. The pattern electroretinogram (PERG) in glaucoma: an evaluation by relative amplitude from the Bjerrum area. Br J Ophthalmol 1990; 73: 131-5.
16. Bray LC, Mitchell KW, Howe JW. Prognostic significance of pattern visual evoked potentials in ocular hypertension. Br J Ophthalmol 1991; 75: 79-83.
17. Bucci MG, Parisi V, Giannini R, Rossini PM. Recordings of visual evoked potentials after photostress in artificially increased intraocular pressure. Clin Vision Sci 1991; 6: 431-6.
18. Parisi V, Bucci MG. Visual evoked potentials after photostress in patients with primary open-angle glaucoma and ocular hypertension. Invest Ophthalmol Vis Sci 1992; 33: 436-42.
19. Parisi V. Neural conduction in the visual pathways in ocular hypertension and glaucoma. Graefe's Arch Clin Exp Ophthalmol 1997; 235: 136-46.
20. Johnson MA, Drum BA, Quigley HA, Sanchez RM, Dunkelberger GR. Pattern-evoked potentials and optic nerve fiber loss in monocular laser-induced glaucoma. Invest Ophthalmol Vis Sci 1989; 30: 897-907.
21. Chaturvedi N, Hedley-Whyte T, Dreyer EB. Lateral geniculate nucleus in Glaucoma. Am J Ophthalmol 1993; 116: 182-188.
22. Dandona L, Hendrickson A, Quigley HA. Selective effects of experimental glaucoma on axonal transport by retinal ganglion cell to the dorsal lateral geniculate nucleus. Invest Ophthalmol Vis Sci 1991; 32: 1593-9.
23. Zappia V, Kennedy P, Nilsson BI, Galletti P. Novel Biochemical, pharmacological and clinical aspects of cytidinediphosphocholine. New York: Elsevier, 1985.
24. Pecori Giraldi J, Virno M, Covelli GP, Grechi G, De Gregorio F. Therapeutic value of citicoline in the treatment of glaucoma (Computerized and automatic perimetric investigation). Int Ophthalmol 1989; 13: 109-15.
25. Parisi V, Manni GL, Colacino G, Gregori D, Bucci MG. Citicoline improves the neural conduction in the visual pathways: an open study in glaucoma patients. Invest Ophthalmol Vis Sci 1998; 39(Suppl): S23.
26. Saletu B, Grunberger JG, et al. Brain protection of Nicergoline against hypoxia: EEG brain mapping and psychometry. J Neural Transm Dis Dement 1990; 2: 305-25.
27. Arrigo A, Moglia A, Borsotti L, Massarini M, Alfonsi E, Battaglia A, Sacchetti GA. Double blind, placebo controlled, cross-over trial with nicergoline in patients with senile dementia. Int Jouranl Clin Pharm Res 1982; 2: 33-41.
28. Marshall J. The effect of Nicergoline on cerebral blood flow. Advisory Service Ltd. Farmitalia, Res. Center Report (confidential) Ott. 1975.
29. Maiolo AT, Bianchi Porro G, et al. Effetti della Nicergolina sull'emodinamica e sul metabolismo dell'encefalo nell'ipertensione arteriosa primaria e nell'arterio sclerosi. Clin Terap 1972; 3: 239-52.
30. Shintomi K. Pharmacological study of nicergoline. Effects on regional cerebral blood flow and arterial carbon dioxide and oxygen pressure and pH in rats under cyanide-induced istotoxic anoxia. Arzneimhelforschung 1991; 41: 885-90.
31. Pasotti G, Liverta C, Cacciatori D, Pollini C. Attività terapeutica della nicergolina nel trattamento delle vasculopatie cerebrali e periferiche. Il Farmaco Ed Pr 1974; 29: 508-19.
32. Migne J, Santonia B. Inhibitin of human platelet aggregation by an alpha-adrenergic blocking agent: in vitro study. First Meeting European Div Int Soc Haematology, Milan 10-12 September 1971; 360.
33. Lanza F, Cazenave J. Potentiation by adrenaline of human platelet activation and the inhibition by the alpha-adrenergic antagonist nicergoline of platelet adhesion, secretion and aggregation. Agents Action 1986; 5-6: 586-95.
34. Bee P, De Bernardi M, Manzo L, Ferrara A, Panceri P, Arrigoni E, Bertè F. Etude de l'action de la nicergoline en ophthalmologie. Gaz Med France 1976; 83: 2119-22.
35. Borgioli M, Merendino F, Ricci B. Attività terapeutica della nicergolina in oftalmologia. Atti Accademia Medica Lomabarda 1976: 31.
36. Meduri R, Piccinni Leopardi G, Maccolini E, Giovannini A, Puglioli R. Semeiologia fisiodinamica oculo-cerebrale. Osservazioni cliniche sugli effetti distrettuali e sul'attività terapeutica della nicergolina. Atti Accademia Medica Lomabarda 1976: 34.
37. Di Meo A, Foria C, De Novellis V. Valutazione dell'influenza di una terapia orale con nicergolina sugli indici perimetrici rilevati in pazienti glaucomatosi. Verona, Italy: Atti SIPE, 1997: 17-18.
38. Drago F, Spampinato D, Marino V, Villa reale G. Biochemical changes after acute and chronic ischaemia and after chronic treatment with β-blockers. ARVO Meeting 1992: 608.
39. Gottlob I, Weghaupt H, Vass C, Auff E. Effect of levodopa on the human electroretinogram and pattern visual evoked potentials. Graefe's Arch Clin Exp Ophthalmol 1989; 227: 421-27.
40. Parisi V, Manni GL, Sgrulletta R, Colacino G, Centofanti M, Bucci MG. Delayed post-retinal neural conduction in glaucoma patients: correlation between electrophysiological and computerized static perimetry parameters. Acta Ophthalmol 1997; 75 (Suppl 224): 31-2.